Skip to main content
Journal cover image

Cognitive enhancers for the treatment of ADHD.

Publication ,  Journal Article
Bidwell, LC; McClernon, FJ; Kollins, SH
Published in: Pharmacol Biochem Behav
August 2011

Attention-deficit hyperactivity disorder (ADHD) is associated with multiple cognition-related phenotypic features in both children and adults. This review aims to clarify the role of cognition in ADHD and how prevailing treatments, which are often highly effective at reducing the clinical symptoms of the disorder, fare in modulating ADHD-related cognitive processes. First, we consider how the broad construct of cognition can be conceptualized in the context of ADHD. Second, we review the available evidence for how a range of both pharmacological and non-pharmacological interventions have fared with respect to enhancing cognition in individuals affected by this pervasive disorder. Findings from the literature suggest that the effects across a broad range of pharmacological and non-pharmacological interventions on the characteristic symptoms of ADHD can be distinguished from their effects on cognitive impairments. As such the direct clinical relevance of cognition enhancing effects of different interventions is somewhat limited. Recommendations for future research are discussed, including the identification of cognition-related endophenotypes, the refinement of the ADHD clinical phenotype, and studying the difference between acute and chronic treatment regimens.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Pharmacol Biochem Behav

DOI

EISSN

1873-5177

Publication Date

August 2011

Volume

99

Issue

2

Start / End Page

262 / 274

Location

United States

Related Subject Headings

  • Social Behavior
  • Reward
  • Propylamines
  • Nootropic Agents
  • Neurology & Neurosurgery
  • Methylphenidate
  • Intelligence
  • Humans
  • Guanfacine
  • Executive Function
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Bidwell, L. C., McClernon, F. J., & Kollins, S. H. (2011). Cognitive enhancers for the treatment of ADHD. Pharmacol Biochem Behav, 99(2), 262–274. https://doi.org/10.1016/j.pbb.2011.05.002
Bidwell, L Cinnamon, F Joseph McClernon, and Scott H. Kollins. “Cognitive enhancers for the treatment of ADHD.Pharmacol Biochem Behav 99, no. 2 (August 2011): 262–74. https://doi.org/10.1016/j.pbb.2011.05.002.
Bidwell LC, McClernon FJ, Kollins SH. Cognitive enhancers for the treatment of ADHD. Pharmacol Biochem Behav. 2011 Aug;99(2):262–74.
Bidwell, L. Cinnamon, et al. “Cognitive enhancers for the treatment of ADHD.Pharmacol Biochem Behav, vol. 99, no. 2, Aug. 2011, pp. 262–74. Pubmed, doi:10.1016/j.pbb.2011.05.002.
Bidwell LC, McClernon FJ, Kollins SH. Cognitive enhancers for the treatment of ADHD. Pharmacol Biochem Behav. 2011 Aug;99(2):262–274.
Journal cover image

Published In

Pharmacol Biochem Behav

DOI

EISSN

1873-5177

Publication Date

August 2011

Volume

99

Issue

2

Start / End Page

262 / 274

Location

United States

Related Subject Headings

  • Social Behavior
  • Reward
  • Propylamines
  • Nootropic Agents
  • Neurology & Neurosurgery
  • Methylphenidate
  • Intelligence
  • Humans
  • Guanfacine
  • Executive Function